Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients

[1]  P. Janský,et al.  Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19 , 2022, Neurology.

[2]  P. Libby,et al.  Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis , 2022, The American Journal of Pathology.

[3]  Nicola Clementi,et al.  Unconventional CD147‐dependent platelet activation elicited by SARS‐CoV‐2 in COVID‐19 , 2021, Journal of Thrombosis and Haemostasis.

[4]  W. Brinjikji,et al.  Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn? , 2021, Stroke.

[5]  R. Delgado-Mederos,et al.  Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke , 2021, Stroke.

[6]  A. Mebazaa,et al.  Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome , 2021, European heart journal.

[7]  G. Paolisso,et al.  SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction , 2021, Critical Care.

[8]  R. Cavallazzi,et al.  A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients , 2021, JCI insight.

[9]  B. Becher,et al.  Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia , 2021, Immunity.

[10]  M. Filippi,et al.  Cerebral thrombi of cardioembolic etiology have an increased content of neutrophil extracellular traps , 2021, Journal of the Neurological Sciences.

[11]  C. Zimmer,et al.  COVID-19-associated Large Vessel Stroke in a 28-year-old Patient , 2021, Clinical Neuroradiology.

[12]  R. Virmani,et al.  Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. , 2021, Circulation.

[13]  M. Netea,et al.  Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients , 2021, Genome medicine.

[14]  H. Markus,et al.  Stroke in COVID-19: A systematic review and meta-analysis , 2020, International journal of stroke : official journal of the International Stroke Society.

[15]  A. Andiappan,et al.  Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19 , 2020, Nature Communications.

[16]  Zhi Mao,et al.  Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis , 2020, Critical Care.

[17]  I. Amit,et al.  Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 , 2020, Cell.

[18]  M. Rudelius,et al.  Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy , 2020, Circulation.

[19]  C. D. Dela Cruz,et al.  Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study , 2020, The Lancet Haematology.

[20]  D. Leaf,et al.  COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection , 2020, Blood.

[21]  W. Lipkin,et al.  Neurologic manifestations in an infant with COVID-19 , 2020, Neurology.

[22]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[23]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[24]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[25]  Xiaowei Yan,et al.  Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 , 2020, The New England journal of medicine.

[26]  M. Filippi,et al.  Leukocyte Counts and Ratios Are Predictive of Stroke Outcome and Hemorrhagic Complications Independently of Infections , 2020, Frontiers in Neurology.

[27]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[28]  G. Danzi,et al.  Acute pulmonary embolism and COVID-19 pneumonia: a random association? , 2020, European heart journal.

[29]  K. Hashimoto,et al.  Nervous system involvement after infection with COVID-19 and other coronaviruses , 2020, Brain, Behavior, and Immunity.

[30]  Fabian J Theis,et al.  SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.

[31]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[32]  P. Espinosa,et al.  Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy , 2020, Cureus.

[33]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[34]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[35]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[36]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[37]  M. Bacigaluppi,et al.  Insights from thrombi retrieved in stroke due to large vessel occlusion , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  M. Kuo,et al.  Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients , 2019, Radiology.

[39]  G. Szabo,et al.  Hypoxia downregulates protein S expression. , 2018, Blood.

[40]  Publisher's Note , 2018, Anaesthesia.

[41]  A. Demchuk,et al.  CT Angiography Clot Burden Score and Collateral Score: Correlation with Clinical and Radiologic Outcomes in Acute Middle Cerebral Artery Infarct , 2009, American Journal of Neuroradiology.

[42]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.